Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 101

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 101
---
 affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
We have not identified any critical accounting estimates.

<div align='center'>62

MANAGEMENT</div>

Directors, Executive Officers and Corporate Governance

As of the date of this prospectus, our current directors and executive
officers are as follows:

| Name            |     | Age |     | Position                              |
| Kuk Hyoun Hwang |     |  49 |     | Chief Executive Officer and President |
| Jun Chul Whang  |     |  60 |     | Chief Legal Officer and Secretary     |
| Sang Hoon Kim   |     |  51 |     | Head of Corporate Venture Capital     |
| Gihyoun Bang    |     |  47 |     | Chief Financial Officer               |
| Constance Höfer |     |  56 |     | Chief Scientific Officer              |
| Phil Geon Lee   |     |  57 |     | Lead Independent Director             |
| Alcide Barberis |     |  66 |     | Independent Director                  |
| Seng Chin Mah   |     |  65 |     | Independent Director                  |
| Jin Whan Park   |     |  57 |     | Independent Director                  |
| Sang Hyun Kim   |     |  54 |     | Independent Director                  |
| Hyuk Joo Jee    |     |  57 |     | Independent Director                  |
| Joong Myung Cho |     |  75 |     | Independent Director                  |

Kuk Hyoun Hwang has been the Chief
Executive Officer and a director of OSR since March 2020. Mr. Hwang is also the President and Chief Executive Officer of the Company
as of the Closing of the Business Combination. Mr. Hwang is the Managing Partner of BCM, which he founded in August 2012. Since then,
he has led BCM’s and its subsidiaries’ growth and expansion as a cross-border healthcare investment group in three countries:
the U.S., South Korea and Switzerland. He is also the Chief Executive Officer of BCME, a position he has held since March 2020, and the
Chairman of the Board of Vaximm AG since November 2022. Since July 2019 until April 2021 and December 2022 to August